Bioequivalence of An Oral Mercaptopurine Suspension 100 Mg / 5 Ml Versus Tablet in Healthy Male Subjects Under Fasting Conditions

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Nova Laboratories Limited
ClinicalTrials.gov Identifier:
NCT01697020
First received: September 20, 2012
Last updated: November 28, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)